Peregrine Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Peregrine Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-384,608	Closed	-$3.63M	–	330
2023 Q3	$3.63M	Sell	384,608 -23,478	-6%	-$283K	0.11%	240
2023 Q2	$5.7M	Sell	408,086 -140	-0%	-$2.39K	0.16%	234
2023 Q1	$7.66M	Buy	408,226 +11,622	+3%	+$191K	0.22%	201
2022 Q4	$5.46M	Sell	396,604 -11,666	-3%	-$179K	0.17%	228
2022 Q3	$7.81M	Sell	408,270 -22,553	-5%	-$411K	0.25%	184
2022 Q2	$6.57M	Buy	430,823 +74	+0%	+$1.09K	0.2%	224
2022 Q1	$8.77M	Sell	430,749 -31,647	-7%	-$644K	0.21%	200
2021 Q4	$13.5M	Buy	462,396 +12,935	+3%	+$370K	0.27%	118
2021 Q3	$9.7M	Buy	449,461 +118,463	+36%	+$2.86M	0.2%	213
2021 Q2	$8.49M	Buy	+330,998	New	+$7.07M	0.15%	245

Other funds holding CDMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Peregrine Capital Management's CDMO Position: Q4 2023 in Review

Peregrine Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 384,608 shares — an estimated $3.63M sold.

Peregrine Capital Management first reported a position in CDMO in Q2 2021 and held it in 10 quarters. The position peaked at $13.5M in Q4 2021. 175 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

Peregrine Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Peregrine Capital Management sold 384,608 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $3.63M.
Peregrine Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
Peregrine Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $13.5M in Q4 2021.
175 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on Peregrine Capital Management's 13F filing for Q4 2023, filed 26 Jan 2024.